Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptorsSzabolcs Dvorácskó, Csaba Tömböly, Mária A. Deli et al.|European Journal of Medicinal Chemistry|2019Cited by 33
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential InteractionsFerenc Zádor, László Vécsei, Gábor Nagy-Grócz et al.|Molecules|2019Cited by 30
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophreniaEdina Szűcs, Sándor Benyhe, Szabolcs Dvorácskó et al.|Neuroscience Letters|2016Cited by 28
Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivativesEdina Szűcs, Ferenc Ötvös, János Marton et al.|European Journal of Medicinal Chemistry|2020Cited by 12